D. Branney

发表

Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial.

John A Sanner, C. Callaway, R. Bellomo, 2022, Intensive care medicine.

Oxygen targets and 6-month outcome after out of hospital cardiac arrest: a pre-planned sub-analysis of the targeted hypothermia versus targeted normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial

John A Sanner, C. Callaway, R. Bellomo, 2022, Critical Care.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Scott M Elliott, J. Haughney, V. Libri, 2021, The Lancet.

Postoperative continuous positive airway pressure to prevent pneumonia, re-intubation, and death after major abdominal surgery (PRISM): a multicentre, open-label, randomised, phase 3 trial.

Mohammed Salah Ibrahim, M. Antonelli, G. Grasselli, 2021, The Lancet. Respiratory medicine.

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

J. Haughney, V. Libri, M. Kamal, 2022, The Lancet Infectious Diseases.

Winning abstracts from The National Acute Pain Symposium 2018

Alison Thomas, D. Branney, E. O'shea, 2019, British Journal of Pain.

Fluid Optimisation in Emergency Laparotomy (FLO-ELA) Trial: study protocol for a multi-centre randomised trial of cardiac output-guided fluid therapy compared to usual care in patients undergoing major emergency gastrointestinal surgery

Grant T. Gibson, Peter D. Campbell, Thomas W. Judd, 2023, Trials.

Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Matthew A. Wiles, Ellen C. Smith, Jack D. Sanders, 2023, Nature.

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Matthew A. Wiles, Ellen C. Smith, Jack D. Sanders, 2023, Nature.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

A second update on mapping the human genetic architecture of COVID-19

M. A. Hakim Newton, Jack D. Sanders, Jonathan H. Morgan, 2022, Nature.

Peer Review File Manuscript Title: Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19 Reviewer Comments & Author Rebuttals

Mohammed A. Eid, Daniel J. Wilson, Nathan D. Berkowitz, 2022 .

Whole-genome sequencing reveals host factors underlying critical COVID-19

Eurie L. Hong, Mohammed A. Eid, Daniel J. Wilson, 2022, Nature.

Stratified analyses refine association between TLR7 rare variants and severe COVID-19

K. Rawlik, N. Sacchi, N. Love, 2024, HGG advances.